Advanced Oncotherapy #AVO – Hardman & Co Research: Confidence greatly boosted

Confidence greatly boosted: Advanced Oncotherapy (AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones were achieved in 2017 and the company remains on track with its development plan. Confidence has been enhanced significantly with integration of the first three structures and […]

Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase

Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase Distribution agreement and capital increase: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in 2017 and the company remains on track with its development plan to deliver […]

Advanced Oncotherapy (AVO) – Hardman Research: Delivery of LIGHT

Delivery of LIGHT: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage with construction work on its Harley Street site expected to commence this month following preliminary assessment work. Meanwhile, individual modules for the LIGHT […]

Hardman & Co – Advanced Oncotherapy (AVO) – China- an emerging opportunity

Advanced Oncotherapy (AVO) – Focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland. Commercial momentum is building, having recently secured a second purchase order in China, formed a JV with Circle to operate potentially the first proton therapy facility […]